National and Kapodistrian University of Athens
Μελέτη των σηματοδοτικών οδών BRAF/MEK/ERK και AKT/mTOR στη λευχαιμία εκ τριχωτών κυττάρων
Abstract
dc:descriptionIntroduction: BRAFV600E has been proven the molecular hallmark in Hairy Cell Leukemia (HCL) lymphomagenesis. ΑΚΤ/mTOR pathway plays critical role in cell proliferation, differentiation and migration and is interconnected with MAPK signalling in several points. This study investigates for the first time the potential ΑΚΤ/mTOR pathway activation in HCL and its interconnection with ΜΑΡΚ signalling, with correlation of the results to the clinicopathological and bone marrow (BM) microvascular characteristics. ΑΚΤ/mTOR and MAPK protein expression was also detected with Western blot in a limited number of cases. Moreover, BRAFV600E mutation was identified by molecular methods in BM samples, while we compared the ΑΚΤ/mTOR pathway activation in ΒΟΝΝΑ-12 cell line before and after the transfection with a BRAFV600E mutant.Methods: BRAFV600E mutant protein as well as phosphorylated (p-) ERK1/2, mTOR, p70S6K, 4E-BP1 and ΑΚΤ were immunohistochemically detected in 77 HCL cases and also by Western blot in 7 cases. Furthermore, the proteins were also immunohistochemically studied in 16 low grade Β cell lymphomas for comparison. The results were correlated with the patients’ clinicopathological characteristics, and microvascular BM features in 36 cases. 35 cases were investigated for BRAFV600E mutation by sequencing, pyrosequencing and High Resolution Melting Analysis (HRMA). ΒΟΝΝΑ-12 cell line was transfected with BRAFV600E mutant plasmid and subsequently BRAFV600E, p-ERK1/2, p-mTOR, p-p70S6K, p-4E-BP1 και p-ΑΚΤ protein levels were measured by Western blot in wild-type and BRAFV600E mutated cells before and after rapamycin treatment, while cell proliferation was determined by MTS assay.Results: All cases were positive for BRAFV600E and p-ERK1/2 proteins and most cases were also positive for p-p70S6K, p-4E-BP1 and p-ΑΚΤ (93,5%, 97,4% και 96,1% respectively). p-mTOR expression was noted only in 12,99% of the cases. Other low grade Β cell lymphomas were negative for BRAFV600E and p-ERK1/2. Western blot results were respective to immunohistochemistry results. Molecular studies identified BRAFV600E mutation in 30/35 cases. BRAFV600E protein was positively correlated with p-p70S6K nuclear expression, p-4E-BP1 cytoplasmic expression and p-ERK1/2 nuclear/cytoplasmic expression. Cytoplasmic p-ERK1/2 was correlated with p-mTOR, cytoplasmic p-p70S6K and cytoplasmic p-4E-BP1, whereas there was correlation of p-mTOR expression with all AKT/mTOR pathway proteins. p-AKT expression was related to nuclear (but not cytoplasmic) p-p70S6K expression. As far as clinicopathological and microvascular features are concerned, p-ERK1/2 was inversely correlated with haemoglobin levels and absolute platelet number (cytoplasmic expression) and positively correlated to shape factor (nuclear expression) and BRAFV600E showed inverse correlation with absolute platelet number and absolute neutrophil number. In univariate survival analysis, increased BM infiltration by hairy cells, reduced haemoglobin levels, younger age, increased p-AKT, cytoplasmic p-ERK1/2, cytoplasmic p-4E-BP1, p-mTOR and BRAFV600E expression as well as simultaneous increased expression of p-AKT/ cytoplasmic p-mTOR/ cytoplasmic p-4E-BP1 were correlated with shorter time to next treatment (TNT). The coexpression of the three molecules remains significant in multivariate survival analysis, as well as the degree of BM infiltration by hairy cells. When p-AKT, p-mTOR and p-4E-BP1 were entered separately in Cox’s model, only the latter emerged as an independent predictor of adverse prognosis. Finally, ΒΟΝΝΑ-12 cells showed increased p-ΕRΚ1/2, p-mTOR, p-p70S6K and p-4E-BP1 levels and increased proliferation after transfection with BRAFV600E mutant. The latter finding was relatively stable also after rapamycin treatment.Conclusions: .Our findings provide evidence about ΑΚΤ/mTOR pathway activation in HCL for the first time and show, through powerful correlations of the proteins that activate or are activated by mTOR and of the integral RAF-MEK-ERK proteins, the interconnection between the two pathways. Of note is that p-4E-BP1 expression, alone or in combination with p-AKT and p-mTOR expression is brought forward as an independent predictor of earlier relapse in HCL.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2017
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Lakiotaki, Eleftheria
- Λακιωτάκη, Ελευθερία
Subjects
dc:subject × 6Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/42003